More on YDES
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $3.67 |
|
|||
| Open | $3.67 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $3.88 | ||||
| Day Low | $3.29 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 687,085 | ||||
- YD Bio Limited Reports Unaudited Financial Results for the Six Months Ended June 30, 2026
- YD Bio publishes peer-reviewed article in Nutrients journal
- YD Bio Announces Peer-Reviewed Publication in Nutrients, Co-Authored with Physicians from the Taiwan Chronic Disease Healthcare Association and the Future Health Institute
- Form 424B3 YD Bio Ltd
- Form 6-K YD Bio Ltd For: Aug 11
- YD Bio launches two nutraceutical products in Taiwan with physicians
- YD Bio Launches a Physician-Partnership Initiative in Taiwan with the Announcement of Two Nutraceutical Products in Collaboration with the Taiwan Chronic Disease Healthcare Association and the Future
- YD Bio publishes keratoconus computational research in Bioengineering
- YD Bio Highlights Peer-Reviewed Publication on New Computational Framework for Keratoconus Research
- YD Bio starts six-month cancer test pilot in British Columbia
Entities mentioned with YDES
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- SPAC | View Related Stories »
- Earnings | View Related Stories »
- 13G | View Related Stories »
- Show More...
